US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
445 deals · US$333bndisclosed · Healthcare · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Apr 2024 | Model N | – | Vista Equity Partners | Acquisition | Completed | 1,250.0 | Vertical SaaS+1 | Jefferies (sell-side)Fenwick & West (sell-side)Kirkland & Ellis (buy-side)William Blair (buy-side) |
| Aug 2024 | CuraLinc Healthcare | – | Lightyear Capital | Stake | Completed | – | Healthcare Services+1 | Davis Polk (buy-side)Houlihan Lokey (buy-side) |
| Oct 2024 | Marquee Health | – | CuraLinc Healthcare | Acquisition | Completed | – | Healthcare Services+1 | Davis Polk (buy-side) |
| Jan 2025 | ImaginAb therapeutic candidates, biologics technology platform and research facility | ImaginAb | Telix Pharmaceuticals | Asset sale | Completed | 45.0 | Healthcare+1 | Jefferies (sell-side)Stifel (sell-side) |
| Feb 2025 | AdvanCell | – | SV Health Investors | Stake | Completed | – | Healthcare+1 | Johnson Winter Slattery (buy-side)Honigman (buy-side) |
| Feb 2025 | Mayne Pharma Group | – | Cosette Pharmaceuticals | Scheme | Withdrawn | 417.9 | Healthcare+1 | Jefferies (sell-side)Gilbert + Tobin (sell-side)Arnold & Porter (sell-side)Davis Wright Tremaine (sell-side)EY (sell-side)Deloitte (sell-side)Santander (buy-side)UBS (buy-side)Corrs Chambers Westgarth (buy-side)Ropes & Gray (buy-side) |
| Feb 2025 | Instinct Bio Technical Company | – | Relativity Acquisition Sponsor | Merger | Pending | 225.0 | Biotech | Hunter Taubman Fischer & Li (sell-side)Chardan (sell-side)Loeb & Loeb (buy-side)Ogier (buy-side) |
| Jun 2025 | Felix Pharmaceuticals Pvt | – | Advent International | Stake | Announced | – | Animal Health+2 | A&L Goodbody LLPLincoln International (sell-side)Guggenheim Securities (buy-side) |
| Jul 2025 | Invacare Holdings S.à r.l. and certain affiliates | Invacare | investment vehicles affiliated with Rhône Capital L.L.C. | Acquisition | Completed | – | Medtech | |
| Jul 2025 | DiamiR Biosciences Corp. | – | Aptorum Group | Merger | Completed | – | Diagnostics+1 | H.C. Wainwright & Co. (sell-side) |
| Jul 2025 | BD Biosciences & Diagnostic Solutions business | Becton, Dickinson and Company | Waters | Asset sale | Completed | 18,800.0 | Life Sciences+2 | Citi (sell-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Barclays (buy-side)Kirkland & Ellis (buy-side) |
| Jul 2025 | DONTE GROUP | Advent International | Ontario Teachers’ Pension Plan Board | Acquisition | Announced | – | Healthcare Services | J.P. Morgan (sell-side) |
| Jul 2025 | Altanine | – | Polomar Health Services | Merger | Pending | – | Healthcare+1 | |
| Jul 2025 | Iodine Software | Advent International | Waystar | Acquisition | Announced | 1,250.0 | Healthcare Software+1 | J.P. Morgan (sell-side)Weil, Gotshal & Manges (sell-side)Barclays (buy-side)Simpson Thacher & Bartlett (buy-side) |
| Aug 2025 | PatientPoint | – | Advent International | Acquisition | Announced | – | Advertising and marketing+2 | Jefferies (sell-side)Citi (sell-side)Gibson Dunn (sell-side)Solomon Partners (buy-side)Ropes & Gray (buy-side) |
| Sep 2025 | Solventum purification and filtration (P&F) business | Solventum Corp | Thermo Fisher Scientific | Asset sale | Announced | 4,000.0 | Medtech | Clayton Utz (sell-side)Cleary Gottlieb Steen & Hamilton (sell-side) |
| Sep 2025 | Zentiva | Advent International | GTCR | Acquisition | Announced | – | Pharma+1 | Goldman Sachs (sell-side)PJT Partners (sell-side)Freshfields (sell-side)Barclays (buy-side)BNP Paribas (buy-side)Morgan Stanley (buy-side)Kirkland & Ellis (buy-side) |
| Oct 2025 | SWK Holdings | – | Runway Growth Finance Corp. | Acquisition | Completed | 249.0 | Financial Services+1 | Keefe, Bruyette & Woods (sell-side)Goodwin (sell-side)Kroll (sell-side)Simpson Thacher & Bartlett (buy-side)Dechert (buy-side) |
| Oct 2025 | Astria Therapeutics | – | BioCryst Pharmaceuticals | Acquisition | Completed | 700.0 | Biotech+2 | Evercore (sell-side)Sidley Austin (sell-side)BofA Securities (buy-side)Covington & Burling (buy-side) |
| Oct 2025 | Avidity Biosciences | – | Novartis | Acquisition | Announced | 11,000.0 | Biotech+2 | Goldman Sachs (sell-side)Barclays (sell-side)Kirkland & Ellis (sell-side)Covington & Burling (buy-side)Freshfields (buy-side)Gordon Dyal & Co. (buy-side) |
| Oct 2025 | Tennova Healthcare Clarksville hospital and ancillary business joint ventures | Community Health Systems subsidiaries | Vanderbilt University Medical Center subsidiaries | Acquisition | Completed | 623.0 | Healthcare Services | Leerink Partners (sell-side) |
| Nov 2025 | CNL Healthcare Properties | – | Sonida Senior Living | Merger | Completed | 1,800.0 | REITs+1 | KeyBanc Capital Markets (sell-side)Ropes & Gray (sell-side)Arnold & Porter (sell-side)RBC Capital Markets (buy-side)Fried Frank (buy-side)Sidley Austin (buy-side)BMO Capital Markets (buy-side)Newmark (buy-side) |
| Nov 2025 | Aptose Biosciences | – | HS North America | Acquisition | Announced | – | Biotech+2 | Locust Walk (sell-side)Stikeman Elliott (buy-side) |
| Nov 2025 | Exact Sciences | – | Abbott | Acquisition | Announced | 23,000.0 | Diagnostics | Centerview Partners (sell-side)XMS Capital Partners (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Wachtell, Lipton, Rosen & Katz (buy-side) |
| Dec 2025 | Pro Care Unlimited | – | Abound Health Group | Acquisition | Completed | – | Healthcare Services+1 | Capstone Partners (sell-side) |
| Dec 2025 | Saisystems Health | – | Serent Capital | Acquisition | Completed | – | Healthcare Software | Capstone Partners (sell-side) |
| Dec 2025 | MindWave Innovations | – | Apimeds Pharmaceuticals US | Merger | Completed | – | Biotech+1 | Duane Morris (sell-side)Nelson Mullins Riley & Scarborough (buy-side) |
| Dec 2025 | Freenome Holdings | – | Perceptive Capital Solutions Corp | Merger | Completed | 725.0 | Diagnostics+2 | TD Securities (sell-side)Guggenheim Securities (sell-side)BTIG (sell-side)Goodwin (sell-side)Greenberg Traurig (sell-side)Richards, Layton & Finger (sell-side)H.C. Wainwright & Co. (sell-side)Jefferies (buy-side)Leerink Partners (buy-side)Cooley (buy-side)Ropes & Gray (buy-side)Maples Group (buy-side)Ogier (buy-side)Scalar (buy-side) |
| Dec 2025 | Quipt Home Medical Corp. | – | 1567208 B.C. | Scheme | Completed | – | Healthcare Services+1 | Evans & Evans (sell-side)Truist Securities (sell-side)DLA Piper (sell-side)McDermott Will & Schulte (buy-side)Fasken (buy-side)UBS (buy-side) |
| Dec 2025 | Generation Bio Co. | – | XRA 7 Corp. | Acquisition | Announced | – | Biotech+1 | TD Securities (sell-side)WilmerHale (sell-side)Gibson Dunn (buy-side) |
| Dec 2025 | Amicus Therapeutics | – | BioMarin | Acquisition | Announced | 4,800.0 | Biotech+2 | Centerview Partners (sell-side)Goldman Sachs (sell-side)Kirkland & Ellis (sell-side)Morgan Stanley (buy-side)Jones Day (buy-side) |
| Dec 2025 | Bako Diagnostics selected assets | – | Fulgent Genetics | Acquisition | Completed | 56.9 | Diagnostics+1 | Latham & Watkins (sell-side)Piper Sandler (buy-side)Mintz (buy-side) |
| Dec 2025 | Dentira | – | Vista Equity Partners | Stake | Announced | – | Vertical SaaS+1 | Kirkland & Ellis (buy-side) |
| Dec 2025 | Dynavax Technologies | – | Sanofi | Acquisition | Announced | 2,200.0 | Biotech+1 | Centerview Partners (sell-side)Goldman Sachs (sell-side)Cooley (sell-side)Weil, Gotshal & Manges (buy-side) |
| Dec 2025 | FONAR | – | Timothy R. Damadian | Acquisition | Announced | – | Medtech+2 | Marshall & Stevens (sell-side)DLA Piper (sell-side) |
| 2026 | Heritage Imaging | – | Align Capital Partners | Acquisition | Completed | – | Healthcare Services | Cascadia Capital |
| 2026 | TFP Fertility Group | – | Amulet | Stake | Announced | – | Healthcare Services | Lincoln International (buy-side) |
| 2026 | Egetis | – | ANI Pharmaceuticals | Acquisition | Announced | 560.0 | Pharma+1 | Centerview Partners (sell-side) |
| 2026 | Surgery Partners | – | Bon Secours Mercy Health | Acquisition | Announced | 5,700.0 | Healthcare Services | Centerview Partners (sell-side) |
| 2026 | Option Care Health | – | CD&R | Acquisition | Announced | 5,800.0 | Healthcare Services | Centerview Partners (sell-side) |
| 2026 | Calytrix Bio | – | Eli Lilly | Acquisition | Announced | 1,500.0 | Biotech | Centerview Partners (sell-side) |
| 2026 | AttaiBeckley | – | Eli Lilly and Company | Acquisition | Announced | 3,800.0 | Biotech+2 | Moelis & Company (sell-side) |
| 2026 | Dentalcorp | – | GTCR | Acquisition | Announced | – | Healthcare Services | Moelis & Company (buy-side) |
| 2026 | FireFly Biologics | – | J&J | Acquisition | Announced | 1,000.0 | Biotech+1 | Centerview Partners (sell-side) |
| 2026 | Prochant | – | Longshore Capital Partners | Stake | Announced | – | Healthcare Software+1 | Lincoln International (sell-side) |
| 2026 | Technipaq | – | Nelipak Healthcare Packaging | Acquisition | Announced | – | Packaging+1 | Lincoln International (sell-side) |
| 2026 | par8o | Clayton, Dubilier & Rice | NuvemRX | Asset sale | Announced | – | Healthcare Services+1 | Lincoln International (sell-side) |
| 2026 | press ganey | – | Qualtrics International | Acquisition | Announced | 6,800.0 | Healthcare Software+1 | Moelis & Company (sell-side) |
| 2026 | HCTec Partners | – | The CSI Companies | Acquisition | Completed | – | Staffing and HR services+2 | Cascadia Capital |
| 2026 | Sebia | – | Warburg Pincus | Stake | Announced | – | Diagnostics | Moelis & Company (buy-side) |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built